However, there are reports on six of Slc genes (Slc2a10, Slc5A1, Slc5a9, Slc6A14, Slc16A5, Slc25A24) in metabolic diseases including obesity, dyslipidemia, NAFLD, and T2DM. This evidence concerns the gene SLC6A14 and metabolic dysfunction-associated steatotic liver disease.